Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Siemens Healthineers Widens FY25 EPS Range By €0.15 To Absorb Up To €300M In Tariff Costs
Selective Exposure Allows Diagnostics To Avoid Major Disruptions From Europe-US And US-China Trade Tensions.
Jun 02 2025
•
By
Shubham Singh
Siemens Healthineers CEO Bernhard Montag said the company is well-positioned to adapt, but visibility is required for longer-term investment decisions.
(Shutterstock)
More from Strategy
More from Medtech Insight